| 注册
首页|期刊导航|中国医学创新|甲巯咪唑和丙硫氧嘧啶治疗甲亢不良反应临床对比

甲巯咪唑和丙硫氧嘧啶治疗甲亢不良反应临床对比

张玉英

中国医学创新Issue(16):132-133,2.
中国医学创新Issue(16):132-133,2.DOI:10.3969/j.issn.1674-4985.2013.16.066

甲巯咪唑和丙硫氧嘧啶治疗甲亢不良反应临床对比

Clinical Contrast of Adverse Reaction between Methimazole and Propylthiouracil to Treat Hyperthyroidism

张玉英1

作者信息

  • 1. 山东省高密卫生学校 山东 高密 261500
  • 折叠

摘要

Abstract

Objective:To compare the adverse reactions incidence and clinical safety of methimazole and propylthiouracil in the treatment of thyroid function hyperfunction.Method:36 cases of patients of our hospital with hyperthyroidism were retrospectively analyzed which were divided into methimazole treatment group (MMI group) and propylthiouracil treatment group (PTU group) randomly. Clinical and prognosis adverse reactions of the two groups were observed and compared.Result:The incidence of white cells decrease, red blood cells, thrombocytopenia and skin rashes of MMI group after treatment were 22.2%, 11.1%, 5.6%, and 16.7%, which were significantly higher than PTU group (5.6%, 0, 0, 5.6%) (P<0.05). The total rate of ALT, ALP, TBIL and DBIL abnormal were 5.6%, which were significantly lower than PTU group(27.8%)(P< 0.05).Conclusion:Different drugs have different side effects in the treatment of hyperthyroidism thyroid function. MMI has a higher rate to cause hematologic complications and skin rash while PTU has more possibility to damage the liver fuctions.

关键词

甲硫咪唑/丙硫氧嘧啶/甲亢/不良反应

Key words

Methimazole/Propylthiouracil/Hyperthyroidism/Adverse reactions

引用本文复制引用

张玉英..甲巯咪唑和丙硫氧嘧啶治疗甲亢不良反应临床对比[J].中国医学创新,2013,(16):132-133,2.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文